According to Syndax Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 3.23.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.31 | -10.81% |
2022-12-31 | 3.71 | 26.65% |
2021-12-31 | 2.93 | -30.67% |
2020-12-31 | 4.22 | -44% |
2019-12-31 | 7.54 | 261.95% |
2018-12-31 | 2.08 | 1.73% |
2017-12-31 | 2.05 | 32.1% |
2016-12-31 | 1.55 | |
2015-12-31 | N/A | |
2014-12-31 | N/A | |
2013-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | -24.86% | ๐บ๐ธ USA |